Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28% Announces Investment Opinion Announces Investment Opinion: Over Achieving Stocks!

NOTE TO EDITORS: The Following Is An Investment Opinion Issued By

WESTON, FL -- (INTERNET WIRE) -- 06/06/02 -- Keep an eye on LAM Pharmaceutical Corp. (OTCBB: LAMP). The company just released news on exceeding expectations. LAMP is down from almost $6.50 and could be a huge gainer in the short term. Other stock market standouts include Durban Roodepoort Deep Lt. (Nasdaq: DROOY), down 8% on 7 million shares, Tellabs Inc. (Nasdaq: TLAB), down 4% on 6 million shares after announcing industry-first technology solution, and Conexant Systems Inc. (Nasdaq: CNXT), down 6% on 6 million shares after announcing Bluetooth Development Alliance with Extended Systems.

The Nasdaq clung to the flat line till the final minutes of trading, when it shot into the green for a positive close, adding to the gains it managed in the previous session. Technology stocks were under pressure in intra-day dealings, though, on the heels of a couple of high-profile revenue warnings from the likes of Manugistics and Tibco Software." Stated Peter Antipatis in's daily commentary. Continued at

All material herein was prepared by Capital Research Group, Inc. (CRG) based upon information believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. CRG has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. (three hundred seventy five thousand lamp. CRG will receive five hundred thousand shares of lamp if contract is completed) CRG intends to sell its shares. CRG has sold approximately two hundred and seventy five thousand lamp shares to date. CRG may sell its shares for less than the target price given in this opinion. CRG's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Peter Antipatis, CRD number 2955420. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Contact: Charles T. Tamburello, Capital Research Group Inc Phone: 954-217-9555 Fax: 954-389-5756 Email:

Provider ID: 02043096

Sponsored Links
Sponsored Links